Barclays
AGN

Barclays’s Allergan plc AGN Stock Holding History

Barclays’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-157,900
Closed -$28M – 6565
2020
Q1 		$28M Sell
157,900
-195,500
-55% -$36.8M 0.02% 509
2019
Q4 		$67.6M Buy
353,400
+84,100
+31% +$15.2M 0.04% 382
2019
Q3 		$45.3M Sell
269,300
-19,900
-7% -$3.24M 0.03% 501
2019
Q2 		$48.4M Buy
289,200
+62,000
+27% +$8.59M 0.03% 498
2019
Q1 		$33.3M Sell
227,200
-174,200
-43% -$25.3M 0.02% 595
2018
Q4 		$53.7M Sell
401,400
-93,300
-19% -$15.3M 0.04% 357
2018
Q3 		$94.2M Sell
494,700
-253,600
-34% -$46.6M 0.07% 221
2018
Q2 		$125M Buy
748,300
+62,000
+9% +$9.95M 0.11% 152
2018
Q1 		$115M Buy
686,300
+410,300
+149% +$68.8M 0.09% 191
2017
Q4 		$45.1M Sell
276,000
-245,700
-47% -$44.1M 0.04% 456
2017
Q3 		$107M Buy
521,700
+381,300
+272% +$88.7M 0.11% 148
2017
Q2 		$34.1M Sell
140,400
-40,400
-22% -$9.49M 0.04% 397
2017
Q1 		$43.2M Sell
180,800
-136,100
-43% -$31.7M 0.05% 295
2016
Q4 		$66.6M Buy
316,900
+31,900
+11% +$6.61M 0.07% 215
2016
Q3 		$65.6M Sell
285,000
-75,300
-21% -$18.4M 0.07% 200
2016
Q2 		$83.3M Buy
360,300
+69,300
+24% +$16M 0.11% 145
2016
Q1 		$78M Sell
291,000
-280,084
-49% -$80.2M 0.12% 146
2015
Q4 		$178M Buy
571,084
+415,500
+267% +$124M 0.22% 77
2015
Q3 		$42.2M Buy
155,584
+22,700
+17% +$6.97M 0.05% 322
2015
Q2 		$40.3M Sell
132,884
-109,200
-45% -$32.6M 0.05% 370
2015
Q1 		$71.9M Sell
242,084
-1,023,459
-81% -$292M 0.08% 223
2014
Q4 		$325M Buy
1,265,543
+1,048,035
+482% +$262M 0.31% 41
2014
Q3 		$52.4M Buy
217,508
+134,292
+161% +$30.1M 0.05% 312
2014
Q2 		$18.6M Sell
83,216
-167,300
-67% -$34.6M 0.02% 745
2014
Q1 		$51.4M Buy
250,516
+203,040
+428% +$40.2M 0.06% 291
2013
Q4 		$7.98M Sell
47,476
-245,124
-84% -$38.3M 0.01% 1435
2013
Q3 		$42.1M Sell
292,600
-18,700
-6% -$2.49M 0.05% 352
2013
Q2 		$39.3M Buy
+311,300
New +$35.2M 0.05% 333

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Barclays's AGN Position: Q2 2020 in Review

Barclays sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,151,403 shares — an estimated $735M sold.

Barclays first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $765M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Barclays reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Barclays sold 4,151,403 Allergan plc shares in Q2 2020, an estimated $735M.
  • Barclays first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Barclays's Allergan plc position peaked at $765M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.